• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Novocure

< Previous 1 2 3 4 Next >
News headline image
Novocure Announces Optune Lua® Receives Reimbursement Approval in Japan for the Treatment of Non-Small Cell Lung Cancer
March 02, 2026
From Novocure
Via Business Wire
Tickers NVCR
News headline image
Novocure to Participate in 2026 Leerink Global Healthcare Conference
February 27, 2026
From Novocure
Via Business Wire
Tickers NVCR
News headline image
Novocure Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Company Update
February 26, 2026
From Novocure
Via Business Wire
Tickers NVCR
News headline image
Tumor Treating Fields (TTFields) Therapy to be Covered for Patients with Newly Diagnosed Glioblastoma Through British Columbia Cancer (BC Cancer)
February 24, 2026
From Novocure
Via Business Wire
Tickers NVCR
News headline image
U.S. FDA Approves Novocure’s Optune Pax® for the Treatment of Locally Advanced Pancreatic Cancer
February 11, 2026
From Novocure
Via Business Wire
Tickers NVCR
News headline image
Novocure Announces Preliminary Full Year and Fourth Quarter 2025 Performance and Provides Company Update
January 12, 2026
From Novocure
Via Business Wire
Tickers NVCR
News headline image
Novocure to Present at 44th Annual J.P. Morgan Healthcare Conference
December 22, 2025
From Novocure
Via Business Wire
Tickers NVCR
News headline image
Novocure Appoints Company President Frank Leonard as Chief Executive Officer
December 01, 2025
From Novocure
Via Business Wire
Tickers NVCR
News headline image
Novocure to Participate in 37th Annual Piper Sandler Healthcare Conference
November 26, 2025
From Novocure
Via Business Wire
Tickers NVCR
News headline image
Novocure to Participate in 2025 Jefferies Global Healthcare Conference
November 12, 2025
From Novocure
Via Business Wire
Tickers NVCR
News headline image
Novocure Reports Third Quarter 2025 Financial Results
October 30, 2025
From Novocure
Via Business Wire
Tickers NVCR
News headline image
Novocure to Present New Research for Tumor Treating Fields (TTFields) Therapy at European Association of Neuro-Oncology (EANO) Meeting and the European Society for Medical Oncology (ESMO) Congress
October 15, 2025
From Novocure
Via Business Wire
Tickers NVCR
News headline image
Novocure to Report Third Quarter 2025 Financial Results
October 01, 2025
From Novocure
Via Business Wire
Tickers NVCR
News headline image
Novocure to Present Final Results from the Pivotal Phase 3 METIS Trial of its Tumor Treating Fields (TTFields) Therapy for Brain Metastases from Non-Small Cell Lung Cancer at 2025 ASTRO Annual Meeting
September 29, 2025
From Novocure
Via Business Wire
Tickers NVCR
News headline image
Novocure’s Optune Lua® Receives Approval in Japan for the Treatment of Unresectable Advanced/Recurrent Non-Small Cell Lung Cancer (NSCLC)
September 15, 2025
From Novocure
Via Business Wire
Tickers NVCR
News headline image
Novocure Announces Upcoming Investor Events
August 28, 2025
From Novocure
Via Business Wire
Tickers NVCR
News headline image
Novocure Announces Coverage of Tumor Treating Fields (TTFields) Therapy for Patients with Newly Diagnosed Glioblastoma in Spain
August 25, 2025
From Novocure
Via Business Wire
Tickers NVCR
News headline image
Novocure Submits Premarket Approval Application to FDA for Tumor Treating Fields Therapy in Locally Advanced Pancreatic Cancer
August 20, 2025
From Novocure
Via Business Wire
Tickers NVCR
News headline image
Novocure Reports Second Quarter 2025 Financial Results
July 24, 2025
From Novocure
Via Business Wire
Tickers NVCR
News headline image
Novocure to Present Final Secondary Endpoint Data from the Phase 3 PANOVA-3 Trial of Tumor Treating Fields (TTFields) in Pancreatic Cancer at the ESMO Gastrointestinal Cancers Congress 2025
July 01, 2025
From Novocure
Via Business Wire
Tickers NVCR
News headline image
Novocure to Report Second Quarter 2025 Financial Results
June 30, 2025
From Novocure
Via Business Wire
Tickers NVCR
News headline image
Results From the Phase 3 PANOVA-3 Trial of Novocure’s Tumor Treating Fields (TTFields) Therapy for Pancreatic Cancer to be Presented at 2025 ASCO Annual Meeting
May 31, 2025
From Novocure
Via Business Wire
Tickers NVCR
News headline image
Novocure Announces Upcoming Investor Events
May 27, 2025
From Novocure
Via Business Wire
Tickers NVCR
News headline image
Novocure Reports First Quarter 2025 Financial Results
April 24, 2025
From Novocure
Via Business Wire
Tickers NVCR
News headline image
Novocure to Present Results from the Phase 3 PANOVA-3 Clinical Trial of its Tumor Treating Fields (TTFields) Therapy for Pancreatic Cancer as a Late-Breaking Oral Presentation at the 2025 ASCO Annual Meeting
April 23, 2025
From Novocure
Via Business Wire
Tickers NVCR
News headline image
Novocure’s Optune Lua® Receives CE Mark Approval for the Treatment of Metastatic Non-Small Cell Lung Cancer
April 22, 2025
From Novocure
Via Business Wire
Tickers NVCR
News headline image
Novocure to Report First Quarter 2025 Financial Results
April 01, 2025
From Novocure
Via Business Wire
Tickers NVCR
News headline image
Novocure to Participate in Leerink Partners 2025 Global Healthcare Conference
March 04, 2025
From Novocure
Via Business Wire
Tickers NVCR
News headline image
Novocure Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Company Update
February 27, 2025
From Novocure
Via Business Wire
Tickers NVCR
News headline image
Novocure Announces Preliminary Full Year and Fourth Quarter 2024 Performance and Provides Company Update
January 13, 2025
From Novocure
Via Business Wire
Tickers NVCR
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap